Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia

Published:2021-06-17 Issue:7 Volume:35 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Pang Nannan¹²,Alimu Xierenguli¹,Chen Rong¹,Muhashi Maliya¹,Ma Jiajia¹,Chen Gang¹,Zhao Fang¹,Wang Lei¹,Qu Jianhua¹,Ding Jianbing³^ORCID

Affiliation:

1. Center of Hematology The First Affiliated Hospital of Xinjiang Medical UniversityHematology Institute of Xinjiang Uygur Autonomous Region Urumqi China

2. State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia The First Affiliated Hospital of Xinjiang Medical University Urumqi China

3. Basic Medical College of Xinjiang Medical University Urumqi China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202100013R

Reference38 articles.

1. The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia

2. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia